Amunix

3 Decision Makers · 5 Verified Contacts & Email Format

📍 South San Francisco, California, United StatesBiotechnology🗓 Est. 2006👥 51–100 employees

About Amunix

Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.

Email Format

{first_letter_first_name}{last_name}@amunix.com — 100.0%

ssmith@amunix.com

Leadership & Decision Makers

Contact details of 3 Amunix decision makers

Volker Schellenberger

Co-Founder, President, and CTO
  • Work email

    v*************r@amunix.com

Shanrong Zhao

Vice President & Head of Bioinformatics, Data Analytics and Library Design
  • Work email

    s***o@amunix.com

Maninder Hora

Chief Technical Operations Officer

Team & Specialists

Contact details of 2 Amunix team members

Walter H. Moos

Board Member

Harold E. Selick

Board Member

General Emails

General company emails, e.g. customer support lines

    bd@amunix.com

    Unclassified inbox

    u003emedia@amunix.com

    Media Relations

    pstemmer@amunix.com

    Unclassified inbox

    ngeething@amunix.com

    Unclassified inbox

Similar Companies like Amunix

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 12/07/2025

650-428-1800

South San Francisco, California, United States

Specialization: Therapeutics,
Legal Name: Amunix Pharmaceuticals, Inc.
Business Type: Private
Employees: 51-100
Rounds: Series B
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series B
Phone Number: 650-428-1800
Last Investment Activity: Feb 9, 2022
Investments Activity: Feb 9, 2022 Dec 21, 2021 Dec 21, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.